Clincosm LogoSign in Get a demo

Bioavailability and Dosing of a Monosaccharide Supplement in Adults

Sponsor
Arkansas Children's Hospital Research Institute (Other)
Overall Status
Completed
CT.gov ID
NCT00782392
Collaborator
University of Arkansas (Other), United States Department of Agriculture (USDA) (U.S. Fed)
15
Enrollment
1
Location

Study Details

Study Description

Brief Summary

We are developing an oral supplement of carbohydrates to be added to infant formulas in order to improve brain development, immune function, and overall health of infants and children. After a careful review of what is known about these sugars, there is very little information regarding their use in infants and children, although there is some information in adults and animals.

Many of these sugars have been used in a glyco-nutritional supplement in adults and children, with minimal or no reported side effects.

We are developing a custom blend of important individual sugars, and need information regarding their dosing and blood concentrations following oral intake of the carbohydrate supplement. Timed blood samples following the carbohydrate supplement will provide us with a better understanding of the most effective dose and the metabolism of these sugars in adults. This will give us the preliminary information we need for developing an oral supplement of special sugars that can be added to infant formulas to help improve brain development and immune function in infants and children.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    15 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Bioavailability and Dosing of an Oral Monosaccharide Supplement in Adults and Effects on Resting Brain Activity
    Study Start Date :
    Jan 1, 2007
    Actual Primary Completion Date :
    Jun 1, 2007

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years to 28 Years
      Sexes Eligible for Study:
      Male
      Accepts Healthy Volunteers:
      Yes
      Inclusion Criteria:

      • Caucasian (non-hispanic)

      • Male

      • Age 18-28

      • Regularly eat breakfast

      • Healthy

      • BMI within normal limits (18.5 - 24.9)

      • English speaking

      Exclusion Criteria:

      • History of smoking, more than occasional alcohol use, or drug use.

      • Chronic medical diagnosis

      • Medications that may interfere with the study

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Arkansas Children's Nutrition Center Little Rock Arkansas United States 72202

      Sponsors and Collaborators

      • Arkansas Children's Hospital Research Institute
      • University of Arkansas
      • United States Department of Agriculture (USDA)

      Investigators

      None specified.

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00782392
      Other Study ID Numbers:
      • 45092
      First Posted:
      Oct 31, 2008
      Last Update Posted:
      May 18, 2011
      Last Verified:
      May 1, 2011
      Keywords provided by , ,
      Nutrition
      Infant Formula

      Study Results

      No Results Posted as of May 18, 2011